Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'guidance purposes'
guidance purposes published presentations and documents on DocSlides.
Cross ward
by lindy-dunigan
c o a t s c o m 00328 08449 08590 00228 09118 09...
Guidance for Industry Contract Manufacturing Arrangements for Drugs Quality Agreements DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only
by tawny-fly
Comments and suggestions regarding this draft doc...
stributed for comment purposes onlyComments and suggestions regarding
by natalia-silvester
G:\4156dft.doc 09/30/03 G:\4156dft.doc http...
Guidance for Industry How to Comply with the Pediatric Research Equity Act DRAFT GUIDANCE This guidance document is being distributed for comment purposes only
by trish-goza
Comments and suggestions regarding this draft doc...
Guidance for Industry Applications for Premarket Review of New Tobacco Products DRAFT GUIDANCE This guidance docume t is being d stributed f r comment purposes only
by myesha-ticknor
Com ents and suggestio ns regar ing this draft do...
Guidance for Industry Developing Products for Weight Management DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only
by stefany-barnette
Comments and suggestions regarding this draft doc...
Guidance for Industry Assessment of Abuse Potential of Drugs DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only
by ellena-manuel
Federal Register Federal Register US Department o...
Guidance for Industry Considerations for the Design of Early Phase Clinical Trials of Cellular and Gene Therapy Products DRAFT GUIDANCE This guidance document is for comment purposes only
by briana-ranney
Submit one set of either electronic or written co...
Guidance for Industry Chronic Fatigue Syndrome Myalgic Encephalomyelitis Developing Drug Products for Treatment DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only
by pamella-moone
Federal Register Federal Register US Department o...
Guidance for Industry Expanded Access to Investigational Drugs for Treatment Use Qs As DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only
by pamella-moone
Comments and suggestions regarding this draft doc...
Guidance for Industry Naming of Drug Products Containing Salt Drug Substances DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only
by karlyn-bohler
Comments and suggestions regarding this draft doc...
ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only
by pasty-toler
Comments and suggestions regarding this draft doc...
Informed Consent Information Sheet Guidance for IRBs Clinical Investigators and Sponsors DRAFT GUIDANCE This guidance document is being distributed for comment purposes only
by cheryl-pisano
Comments and suggestions regarding this draft doc...
Guidance for Industry Complicated Intra Abdominal Infections Developing Drugs for Treatment DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only
by kittie-lecroy
5741157455574535745357445574545746057459573765744...
Guidance for Industry ANDA Submissions Prior Approval Supplements Under GDUFA DRAFT GUIDANCE This guidance document is being distributed for comment purposes only
by conchita-marotz
Comments and suggestions regarding this draft doc...
Scientific Considerations in Demonstrating Biosimilarity to a Reference Product DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only
by mitsue-stanley
5741157455574535745357445574545746057459573765744...
This guidance document is being distributed for comment purposes only.
by luanne-stotts
10873dft.doc 06/26/13 Additional copies are avai...
This guidance document is being distributed for comment purposes only.
by min-jolicoeur
10302dft.doc 08/06/12 Additional copies are availa...
This guidance document is being distributed for comment purposes only.
by tatiana-dople
Additional copies are available from: Office of Tr...
This guidance document is being distributed for comment purposes only.
by alida-meadow
17325dft.doc 06/01/15 Additional copies are avail...
This guidance document is being distributed for comment purposes only.
by myesha-ticknor
Additional copies are available from: Office of Co...
This guidance document is being distributed for comment purposes only.
by conchita-marotz
26170dft.doc 05/22/15 Additional copies are availa...
This guidance document is being distributed for comment purposes only.
by debby-jeon
Additional copies are available from: Office of Co...
This guidance document is being distributed for comment purposes only.
by lindy-dunigan
. All comments should be identified with the dock...
This guidance document is being distributed for comment purposes only.
by pasty-toler
Additional copies are available from: Office of Co...
This guidance document is being distributed for comment purposes only.
by stefany-barnette
Additional copies are available from: Office of Co...
This guidance document is being distributed for comment purposes only.
by tatiana-dople
Additional copies are available from: Office of Co...
This guidance document is being distributed for comment purposes only.
by sherrill-nordquist
15026dft.doc 09/30/14 Additional copies are avail...
This guidance document is being distributed for comment purposes only.
by phoebe-click
11157dft.doc 07/29/15 Additional copies are avail...
x0000x00001 xMCIxD 0 xMCIxD 0 DEPARTMENT OF HEALTH
by singh
��2 &#x/MCI; 0 ;&#x/MCI; 0 ;...
This guidance document is being distributed for comment purposes only
by carla
15028dft.doc 07/27/16 Additional copies are availa...
This guidance document is being distributed for comment purposes only
by obrien
G:\5412dft.doc01/02/03 G:\5412dft.doc01/02/03 The ...
Load More...
